Sequential antibiotic therapy against Helicobacter pylori may result in a better eradication rate than standard triple-drug therapy, an Italian randomised controlled trial has shown. A total of 295 patients with proven H. pylori infection underwent endoscopy, biopsy, and bacterial culture of biopsy specimens. One group of patients received a 10-day sequential regimen of pantoprazole, amoxycillin, clarithromycin, and tinidazole. The other group was given standard 10-day therapy of pantoprazole, clarithromycin, and amoxycillin, each given twice daily. After treatment, patients underwent a second diagnostic 13C-urea breath test to detect presence of H. pylori. Sequential therapy resulted in a greater eradication rate and was significantly more effective in the treatment of clarithromycin-resistant strains.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.